XtalPi, an artificial intelligence drug discovery company, is weighing a new funding round ahead of a potential initial public offering, according to people with knowledge of the matter.
The Alphabet Inc.’s Google-backed startup is working with Goldman Sachs Group Inc. as it seeks to raise about $300 million to $400 million through a private placement, tapping both existing and new investors, the people said. The latest round could boost the company’s valuation to about $1.9 billion, the people said, asking not to be identified as the information isn’t public.
